# WuXi Biologics

Global CDMO powerhouse — open-access biologics platform covering cell line development through Phase 1–3 and commercial manufacturing for 800+ integrated projects.

Source: https://en.bioecon.ru/companies/wuxi-biologics/
Updated: 2026-06-19

- Country: China
- Revenue: RMB 18.7B
- Employees: ~14,000 emp

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | RMB 21.8 billion (2025-12-31) | https://www.prnewswire.com/news-releases/wuxi-biologics-reports-record-2025-annual-results-302723294.html, https://www.wuxibiologics.com/press-release/wuxi-biologics-reports-record-2025-annual-results/ |
| Revenue | RMB 11.8 billion (H1 2026) (2026-06-30) | https://www.prnewswire.com/news-releases/wuxi-biologics-reports-strong-profitable-growth-in-h1-2026-302859399.html, https://www.wuxibiologics.com/press-release/wuxi-biologics-reports-strong-profitable-growth-in-h1-2026/ |
| Capacity | Over 260,000 L of bioreactor capacity with planned increases to exceed 580,000 L (2025-01-09) | https://www.wuxibiologics.com/capabilities/commercial-ds-manufacturing/ |
| Production site | 15 GMP-certified manufacturing facilities (2026-06-30) | https://www.wuxibiologics.com/press-release/wuxi-biologics-reports-strong-profitable-growth-in-h1-2026/ |
| Certification | 166 facility license approvals obtained; 100% success rate across 49 regulatory inspections (since 2017) by authorities including U.S. FDA, EU EMA, and NMPA (2026-08-31) | https://megaproject.com/news/factory/wuxi-biologics-accelerates-development-manufacturing-with-robust-model-platforms, https://www.wuxibiologics.com/press-release/wuxi-biologics-reports-record-2025-annual-results/, https://www.wuxibiologics.com/press-release/wuxi-biologics-reports-strong-profitable-growth-in-h1-2026/ |
| Headcount | 14,705 employees globally (2026-06-30) | https://www.wuxibiologics.com/press-release/wuxi-biologics-reports-record-2025-annual-results/, https://www.wuxibiologics.com/press-release/wuxi-biologics-reports-strong-profitable-growth-in-h1-2026/ |

Independent sources: megaproject.com, prnewswire.com

## Technologies

- [Biologics](https://en.bioecon.ru/technology/biologics/)
- [Bioproduction CDMO/CMO (biologics/ATMP/mRNA)](https://en.bioecon.ru/technology/bioproduction-cdmo-cmo/)
- [Local manufacturing for market access](https://en.bioecon.ru/technology/local-manufacturing-for-market-access/)